Boyan Vesselinov Litchev - Net Worth and Insider Trading
Boyan Vesselinov Litchev Net Worth
The estimated net worth of Boyan Vesselinov Litchev is at least $978 dollars as of 2024-12-27. Boyan Vesselinov Litchev is the Chief Medical Officer of Indaptus Therapeutics Inc and owns about 1,150 shares of Indaptus Therapeutics Inc (INDP) stock worth over $978. Details can be seen in Boyan Vesselinov Litchev's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Boyan Vesselinov Litchev has not made any transactions after 2022-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Boyan Vesselinov Litchev
Boyan Vesselinov Litchev Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Boyan Vesselinov Litchev owns 1 companies in total, including Indaptus Therapeutics Inc (INDP) .
Click here to see the complete history of Boyan Vesselinov Litchev’s form 4 insider trades.
Insider Ownership Summary of Boyan Vesselinov Litchev
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INDP | Indaptus Therapeutics Inc | 2022-12-01 | Chief Medical Officer |
Boyan Vesselinov Litchev Latest Holdings Summary
Boyan Vesselinov Litchev currently owns a total of 1 stock. Boyan Vesselinov Litchev owns 1,150 shares of Indaptus Therapeutics Inc (INDP) as of December 1, 2022, with a value of $978.
Latest Holdings of Boyan Vesselinov Litchev
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
INDP | Indaptus Therapeutics Inc | 2022-12-01 | 1,150 | 0.85 | 978 |
Holding Weightings of Boyan Vesselinov Litchev
Boyan Vesselinov Litchev Form 4 Trading Tracker
According to the SEC Form 4 filings, Boyan Vesselinov Litchev has made a total of 1 transactions in Indaptus Therapeutics Inc (INDP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Indaptus Therapeutics Inc is the acquisition of 1,150 shares on December 1, 2022, which cost Boyan Vesselinov Litchev around $2,519.
Insider Trading History of Boyan Vesselinov Litchev
- 1
Boyan Vesselinov Litchev Trading Performance
GuruFocus tracks the stock performance after each of Boyan Vesselinov Litchev's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Boyan Vesselinov Litchev is -5.03%. GuruFocus also compares Boyan Vesselinov Litchev's trading performance to market benchmark return within the same time period. The performance of stocks bought by Boyan Vesselinov Litchev within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Boyan Vesselinov Litchev's insider trading performs compared to the benchmark.
Performance of Boyan Vesselinov Litchev
Boyan Vesselinov Litchev Ownership Network
Boyan Vesselinov Litchev Owned Company Details
What does Indaptus Therapeutics Inc do?
Who are the key executives at Indaptus Therapeutics Inc?
Boyan Vesselinov Litchev is the Chief Medical Officer of Indaptus Therapeutics Inc. Other key executives at Indaptus Therapeutics Inc include 10 percent owner Glen R. Anderson , Chief Medical Officer Roger J. Waltzman , and director & Chief Executive Officer Jeffrey A Meckler .
Indaptus Therapeutics Inc (INDP) Insider Trades Summary
Over the past 18 months, Boyan Vesselinov Litchev made no insider transaction in Indaptus Therapeutics Inc (INDP). Other recent insider transactions involving Indaptus Therapeutics Inc (INDP) include a net purchase of 103,352 shares made by Glen R. Anderson ,
In summary, during the past 3 months, insiders sold 0 shares of Indaptus Therapeutics Inc (INDP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Indaptus Therapeutics Inc (INDP) were sold and 103,352 shares were bought by its insiders, resulting in a net purchase of 103,352 shares.
Indaptus Therapeutics Inc (INDP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Indaptus Therapeutics Inc Insider Transactions
Boyan Vesselinov Litchev Mailing Address
Above is the net worth, insider trading, and ownership report for Boyan Vesselinov Litchev. You might contact Boyan Vesselinov Litchev via mailing address: 13357 Russet Leaf Ln., San Diego Ca 92129.